Kuecept Information

Kuecept (part of the Aptuit group of companies) is a pharmaceutical Contract Research Organisation based in the UK. Kuecept offers a range of specialist screening and formulation services to develop new and improved delivery systems for poorly soluble and challenging pharmaceutical/biopharmaceutical actives, with particular expertise in oral, parenteral and pulmonary dosage forms. Our tailored services include: • Drug substance profiling and lead candidate selection • Rapid preclinical formulation screening (Solent™) • Formulation concept design • Formulation prototype development In addition to our contract support services, Kuecept has developed its own portfolio of enabling drug delivery technologies to improve drug bioavailabilty, including nano-milling and amorphous form development. These bespoke approaches can be incorporated during any stage of a drug development program, whether there is a need to improve or modulate your compound's in vivo release profile and/or bioavailability, or identify Life Cycle Management opportunities for existing pharmaceutical products. Since our inception in 2007, we have successfully partnered with >50 global customers on programs ranging from drug substance physicochemical profiling and lead compound selection through to developing enabling formulations to support clinical development. For more information on these services or to request a visit, please visit our website http://www.kuecept.com/ or contact us for an informal and confidential discussion.